Skip to main content

Table 2 Characteristics of patients of GCTBa treated with curettage from 2008 to 2010

From: Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Characteristics

No. of patients (%)

Primary tumor site

 Extremity

151 (96%)

 Trunk

7 (4%)

Campanacci grade

 Grade I

16 (10%)

 Grade II

97 (61%)

 Grade III

45 (29%)

Pathological fracture at presentation

 Yes

26 (16%)

 No

132 (84%)

Do you use denosumab for this case now?

 Yes

83 (52%)

 No

75 (48%)

Embolization before surgery

 Yes

8 (5%)

 No

150 (95%)

  1. aGCTB, giant cell tumor of bone